SR-BI mediates high density lipoprotein (HDL)-induced anti-inflammatory effect in macrophages

Miller, 1987, Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis, Am. Heart J., 113, 589, 10.1016/0002-8703(87)90638-7

Subedi, 2014, Current guidelines for high-density lipoprotein cholesterol in therapy and future directions, Vasc. Health Risk Manage., 10, 205

Annema, 2013, High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis, Circ. J., 77, 2432, 10.1253/circj.CJ-13-1025

Rye, 2014, Cardioprotective functions of HDLs, J. Lipid Res., 55, 168, 10.1194/jlr.R039297

Cheng, 2012, Apolipoprotein A-I attenuates palmitate-mediated NF-kappaB activation by reducing Toll-like receptor-4 recruitment into lipid rafts, PLoS ONE, 7, e33917, 10.1371/journal.pone.0033917

Nicholls, 2005, Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits, Circulation, 111, 1543, 10.1161/01.CIR.0000159351.95399.50

Curtiss, 1983, A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glycosylated low density lipoproteins, J. Clin. Invest., 72, 1427, 10.1172/JCI111099

Hurst, 2003, Increased incidence of coronary atherosclerosis in type 2 diabetes mellitus: mechanisms and management, Ann. Intern. Med., 139, 824, 10.7326/0003-4819-139-10-200311180-00010

Park, 2014, Dysfunctional lipoproteins from young smokers exacerbate cellular senescence and atherogenesis with smaller particle size and severe oxidation and glycation, Toxicol. Sci., 140, 16, 10.1093/toxsci/kfu076

Park, 2011, High-density lipoprotein (HDL) from elderly and reconstituted HDL containing glycated apolipoproteins A-I share proatherosclerotic and prosenescent properties with increased cholesterol influx, J. Gerontol. A Biol. Sci. Med. Sci., 66, 511, 10.1093/gerona/glr016

Rhainds, 2004, The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders, Int. J. Biochem. Cell Biol., 36, 39, 10.1016/S1357-2725(03)00173-0

Acton, 1994, Expression cloning of SR-BI, a CD36-related class B scavenger receptor, J. Biol. Chem., 269, 21003, 10.1016/S0021-9258(17)31921-X

Altmann, 2002, The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption, Biochim. Biophys. Acta, 1580, 77, 10.1016/S1388-1981(01)00190-1

Ohgami, 2001, CD36, a member of class B scavenger receptor family, is a receptor for advanced glycation end products, Ann. N. Y. Acad. Sci., 947, 350, 10.1111/j.1749-6632.2001.tb03961.x

Ji, 1999, Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile, J. Biol. Chem., 274, 33398, 10.1074/jbc.274.47.33398

Acton, 1996, Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science, 271, 518, 10.1126/science.271.5248.518

Li, 2002, High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner, J. Biol. Chem., 277, 11058, 10.1074/jbc.M110985200

Havel, 1955, The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum, J. Clin. Invest., 34, 1345, 10.1172/JCI103182

Brewer, 1986, Isolation and characterization of apolipoproteins A-I, A-II, and A-IV, Methods Enzymol., 128, 223, 10.1016/0076-6879(86)28070-2

Park, 2014, Elaidic acid (EA) generates dysfunctional high-density lipoproteins and consumption of EA exacerbates hyperlipidemia and fatty liver change in zebrafish, Mol. Nutr. Food Res., 58, 1537, 10.1002/mnfr.201300955

Park, 2010, Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence, Biochem. Biophys. Res. Commun., 392, 295, 10.1016/j.bbrc.2009.12.179

Gasparini, 2012, NF-kappaB as a target for modulating inflammatory responses, Curr. Pharm. Des., 18, 5735, 10.2174/138161212803530763

Nobecourt, 2010, Nonenzymatic glycation impairs the antiinflammatory properties of apolipoprotein A-I, Arterioscler. Thromb. Vasc. Biol., 30, 766, 10.1161/ATVBAHA.109.201715

van der Vorst, 2013, High-density lipoproteins suppress chemokine expression and proliferation in human vascular smooth muscle cells, FASEB J., 27, 1413, 10.1096/fj.12-212753

Rigotti, 1996, Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-BI), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland, J. Biol. Chem., 271, 33545, 10.1074/jbc.271.52.33545

Tondu, 2005, Insulin and angiotensin II induce the translocation of scavenger receptor class B, type I from intracellular sites to the plasma membrane of adipocytes, J. Biol. Chem., 280, 33536, 10.1074/jbc.M502392200

Ji, 1997, Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux, J. Biol. Chem., 272, 20982, 10.1074/jbc.272.34.20982

Ohgami, 2003, Advanced glycation end products (AGE) inhibit scavenger receptor class B type I-mediated reverse cholesterol transport: a new crossroad of AGE to cholesterol metabolism, J. Atheroscler. Thromb., 10, 1, 10.5551/jat.10.1

Ott, 2014, Role of advanced glycation end products in cellular signaling, Redox Biol., 2, 411, 10.1016/j.redox.2013.12.016